// App-Quantinova.ai

2253 : Factor V Leiden Mutation Increases the Risk of Venous Thromboembolism in Cancer Patients Results From the Vienna Cancer and Thrombosis Study (CATS).

Researchers

Presenter

  • I Pabinger

Principal Investigators

  • C Ay

  • D Dunkler

  • J Thaler

  • E-M Reitter

  • C Marosi

  • C Zielinski

  • C Mannhalter

Medical Centers

  • Clinical Institute of Medical and Laboratory Diagnostics, Medical University of Graz, Graz, Austria

  • Dept. of Medicine I, Div. of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria

  • Center for Medical Statistics, Informatics and Intelligent Systems, Section for Clinical Biometrics, Vienna, Austria

  • Department of Medicine I, Medical University of Vienna, Austria

  • Department of Medicine I, Clinical Division of Haematology and Haemostaseology, Vienna, Austria

  • Dept. of Medicine I, Div. of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria

  • Department of Medicine I, Division of Oncology, Vienna, Austria

Locations

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved